Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Health Canada Approval Recent news which mentions Health Canada Approval From The U.S. To Canada: High-Quality Psilocybin API Gets Green Light For Import June 12, 2023 Tags Psychedelic/Assisted Therapies Benzinga Psychedelics From Benzinga Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal May 11, 2023 Tickers OPTHF Tags Psychedelics Benzinga Psychedelic/Assisted Therapies From Benzinga Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder February 14, 2023 Tickers KONEF NMLSF Tags KGK Sciences Cannabis Market News From Benzinga This Psychedelic-Assisted Therapy Study Offers Therapists Experience With Magic Mushroom Tea February 01, 2023 Tickers NUMIF Tags Cannabis Market News Markets From Benzinga Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce January 24, 2023 Tickers PSYCF PSYGF TRUFF Tags MDMA Therapy Ibogaine PSYCF From Benzinga Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action January 21, 2023 Tickers AMZN CLABF OPTHF TRUFF Tags Market News Cannabis OPTHF From Benzinga First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval December 27, 2022 Tickers KONEF NMLSF Tags Markets Fragile X Syndrome Market News From Benzinga Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial November 30, 2022 Tickers KONEF NMLSF Tags Penny Stocks Health Canada Approval News From Benzinga New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details September 17, 2022 Tickers NMLSF Tags Cannabis Market News Markets From Benzinga Merck Secures Canadian Regulatory Nod For KEYTRUDA In Skin Cancer After Resection September 13, 2022 Tickers MRK Tags Market News General MRK From Benzinga Bristol Myers Squibb Secures Canadian Regulatory Nod For Lung Cancer Candidate In Neoadjuvant Setting August 23, 2022 Tickers BMY Tags Benzinga Health Canada Approval Health Care From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.